| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 1.7% | -0.7% |
| ROCE | 3.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 0.5 | 0.5 |
| Pr/Book | 1.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 24.3% | -14.3% |
| PBT | n/a | n/a |
| EPS | n/a | -50.2% |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-22 | 41.05 | 3.96 | 7.11p | 14.4 | n/a | -7% | 0.61p | 0.6% |
| 31-Jan-23 | 41.23 | 0.08 | 2.99p | 17.4 | n/a | -58% | 0.61p | 1.2% |
| 31-Jan-24 | 37.63 | (5.68) | (8.85)p | n/a | n/a | n/a | 0.20p | 0.5% |
| 31-Jan-25 | 38.25 | (15.75) | (18.82)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Jan-26 | 47.55 | (0.14) | (1.16)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-27 | 40.74 | (0.30) | (0.58)p | n/a | n/a | -50% | n/a | 0.0% |
| 31-Jan-28 | 43.94 | 0.51 | 0.07p | 335.8 | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Final Results | 16-Jun-2026 | 07:00 | RNS |
| Notice of Results | 02-Jun-2026 | 07:01 | RNS |
| Transfer of Non-Core Products to Focus on Neonatal | 02-Jun-2026 | 07:00 | RNS |
| Need to Know: Global Business Briefing | 02-Dec-2006 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 22.68p |
| Change Today | 0.18p |
| % Change | 0.82 % |
| 52 Week High | 31.30 |
| 52 Week Low | 12.75 |
| Volume | 30,238 |
| Shares Issued | 89.66m |
| Market Cap | £20.34m |
| Beta | 0.02 |
| RiskGrade | 227 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 23-Nov-23 | 29-Jun-23 |
| Paid | 22-Dec-23 | 28-Jul-23 |
| Amount | 0.20p | 0.41p |
| Time | Volume / Share Price |
| 11:39 | 20,000 @ 23.00p |
| 10:35 | 157 @ 23.00p |
| 09:08 | 10,050 @ 22.70p |
| 08:55 | 31 @ 23.00p |
| CFO | Alan Olby |
| Chair | Gordon Roy Davis |
| CEO | Harout Rafi |
You are here: research